Black Diamond Therapeutics, Inc.(BDTX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BDTX Black Diamond Therapeutics, Inc.

休市中 02-20 16:00:00 EST

2.33

+0.03

+1.30%

盘后2.29

-0.04-1.72%

18:54 EST

最高2.34	最低2.24	成交量48.23万
今开2.28	昨收2.30	日振幅4.35%
总市值1.33亿	流通市值9,144万	总股本5,697万
成交额110.63万	换手率1.23%	流通股本3,924万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"BDTX","market":"US","secType":"STK","nameCN":"Black Diamond Therapeutics, Inc.","latestPrice":2.33,"timestamp":1771621200000,"preClose":2.3,"halted":0,"volume":482281,"hourTrading":{"tag":"盘后","latestPrice":2.29,"preClose":2.33,"latestTime":"18:54 EST","volume":846,"amount":1956.551,"timestamp":1771631653527,"change":-0.04,"changeRate":-0.017167,"amplitude":0.017167},"delay":0,"changeRate":0.013043478260869674,"floatShares":39244252,"shares":56974913,"eps":0.37788,"marketStatus":"休市中","change":0.03,"latestTime":"02-20 16:00:00 EST","open":2.28,"high":2.34,"low":2.24,"amount":1106289.772786,"amplitude":0.043478,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.37788,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1771837200000},"marketStatusCode":7,"adr":0,"listingDate":1580360400000,"exchange":"NASDAQ","adjPreClose":2.3,"preHourTrading":{"tag":"盘前","latestPrice":2.2701,"preClose":2.3,"latestTime":"08:50 EST","volume":32,"amount":73.2425984,"timestamp":1771595445459,"change":-0.0299,"changeRate":-0.013,"amplitude":0.008652},"postHourTrading":{"tag":"盘后","latestPrice":2.29,"preClose":2.33,"latestTime":"18:54 EST","volume":846,"amount":1956.551,"timestamp":1771631653527,"change":-0.04,"changeRate":-0.017167,"amplitude":0.017167},"volumeRatio":1.2446137736303469,"impliedVol":1.0088,"impliedVolPercentile":0.4502},"requestUrl":"/m/hq/s/BDTX","defaultTab":"news","newsList":[{"id":"2605147440","title":"Black Diamond Therapeutics, Inc.盘中异动 早盘大幅下挫6.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605147440","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605147440?lang=zh_cn&edition=full","pubTime":"2026-01-21 00:19","pubTimestamp":1768925967,"startTime":"0","endTime":"0","summary":"北京时间2026年01月21日00时19分，Black Diamond Therapeutics, Inc.股票出现异动，股价快速下跌6.05%。Black Diamond Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.39%。其相关个股中，Corvus Pharmaceuticals, Inc.、Rapt Therapeutics, Inc.、Aclaris Therapeutics, Inc.涨幅较大，Jaguar Health, Inc.、Rapt Therapeutics, Inc.、Corvus Pharmaceuticals, Inc.较为活跃，换手率分别为122.26%、83.97%、53.81%，振幅较大的相关个股有Corvus Pharmaceuticals, Inc.、Jasper Therapeutics Inc C/Wts 24/09/2026 、Dermata Therapeutics Inc C/Wts ，振幅分别为48.57%、48.50%、41.00%。Black Diamond Therapeutics, Inc.公司简介：Black Diamond Therapeutics Inc 是一家临床阶段的肿瘤学公司，开发针对癌症患者致癌突变家族的 MasterKey 疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260121001927953d9620&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260121001927953d9620&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4539","BK4139","LENZ","BDTX"],"gpt_icon":0},{"id":"2603952570","title":"Black Diamond Therapeutics, Inc.盘中异动 股价大跌5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603952570","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603952570?lang=zh_cn&edition=full","pubTime":"2026-01-12 22:31","pubTimestamp":1768228293,"startTime":"0","endTime":"0","summary":"北京时间2026年01月12日22时31分，Black Diamond Therapeutics, Inc.股票出现异动，股价快速下挫5.34%。Black Diamond Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.64%。其相关个股中，Cdt Equity Inc C/Wts 22/09/2028、Mereo Biopharma Group Plc、Day One Biopharmaceuticals, Inc.涨幅较大，Jaguar Health, Inc.、Osr Holdings, Inc.、Genprex, Inc.较为活跃，换手率分别为495.70%、103.78%、39.92%，振幅较大的相关个股有Zentalis Pharmaceuticals, Inc.、Novabay Pharmaceuticals, Inc.、Newcelx Ltd.，振幅分别为13.10%、10.95%、10.05%。Black Diamond Therapeutics, Inc.公司简介：Black Diamond Therapeutics Inc 是一家临床阶段的肿瘤学公司，开发针对癌症患者致癌突变家族的 MasterKey 疗法。其在研药物为 BDTX-4933 和 BDTX-1535。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112223133953c6c5d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112223133953c6c5d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4539","BK4139","LENZ","BDTX"],"gpt_icon":0},{"id":"1184284519","title":"Black Diamond计划于2026年上半年启动Silevertinib在新诊断胶质母细胞瘤患者中的随机二期临床试验；预计2028年公布初步数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1184284519","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1184284519?lang=zh_cn&edition=full","pubTime":"2025-12-03 20:03","pubTimestamp":1764763388,"startTime":"0","endTime":"0","summary":"Black Diamond计划于2026年上半年启动Silevertinib在新诊断胶质母细胞瘤患者中的随机二期临床试验；预计2028年公布初步数据","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BDTX","BK4139"],"gpt_icon":0},{"id":"1139569651","title":"黑钻石治疗公司申请最高达5亿美元的混合融资 - SEC备案","url":"https://stock-news.laohu8.com/highlight/detail?id=1139569651","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1139569651?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:46","pubTimestamp":1763574399,"startTime":"0","endTime":"0","summary":"11月13日 - 黑钻石治疗公司（Black Diamond Therapeutics Inc）宣布，已提交申请，计划通过混合融资方式筹集最高达5亿美元的资金。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BDTX"],"gpt_icon":0},{"id":"1101646691","title":"黑钻石治药公司：Piper Sandler启动覆盖，给予增持评级；目标价9美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1101646691","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1101646691?lang=zh_cn&edition=full","pubTime":"2025-11-18 12:19","pubTimestamp":1763439549,"startTime":"0","endTime":"0","summary":"黑钻石治药公司：Piper Sandler启动覆盖，给予增持评级；目标价9美元","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BDTX","BK4139"],"gpt_icon":0},{"id":"2577381813","title":"Black Diamond Therapeutics, Inc.盘中异动 早盘股价大跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577381813","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577381813?lang=zh_cn&edition=full","pubTime":"2025-10-21 21:55","pubTimestamp":1761054953,"startTime":"0","endTime":"0","summary":"北京时间2025年10月21日21时55分，Black Diamond Therapeutics, Inc.股票出现异动，股价快速跳水5.10%。Black Diamond Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.66%。其相关个股中，Minerva Neurosciences, Inc、Cero Therapeutics Holdings Inc C/Wts 14/02/2029 、Ibio, Inc.涨幅较大，Minerva Neurosciences, Inc、Ibio, Inc.、Rani Therapeutics Holdings, Inc.较为活跃，换手率分别为1170.40%、160.53%、45.03%，振幅较大的相关个股有Minerva Neurosciences, Inc、Cero Therapeutics Holdings Inc C/Wts 14/02/2029 、Ibio, Inc.，振幅分别为215.34%、78.99%、47.03%。Black Diamond Therapeutics, Inc.公司简介：Black Diamond Therapeutics Inc 是一家临床阶段的肿瘤学公司，开发针对癌症患者致癌突变家族的 MasterKey 疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251021215553a6c60ad8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251021215553a6c60ad8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","BK4139","BK4539","BDTX"],"gpt_icon":0},{"id":"2576061094","title":"Black Diamond Therapeutics, Inc.盘中异动 早盘快速下跌5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2576061094","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576061094?lang=zh_cn&edition=full","pubTime":"2025-10-17 22:22","pubTimestamp":1760710923,"startTime":"0","endTime":"0","summary":"北京时间2025年10月17日22时22分，Black Diamond Therapeutics, Inc.股票出现异动，股价急速下挫5.14%。Black Diamond Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。其相关个股中，Rani Therapeutics Holdings, Inc.、Artiva Biotherapeutics, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大，Xortx Therapeutics Inc.、Rani Therapeutics Holdings, Inc.、Artiva Biotherapeutics, Inc.较为活跃，换手率分别为1371.08%、377.67%、202.54%，振幅较大的相关个股有Apollomics Inc C/Wts 01/04/2028 、Rani Therapeutics Holdings, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026，振幅分别为79.40%、74.33%、61.69%。Black Diamond Therapeutics, Inc.公司简介：Black Diamond Therapeutics Inc 是一家临床阶段的肿瘤学公司，开发针对癌症患者致癌突变家族的 MasterKey 疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101722220397341b70&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101722220397341b70&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","BDTX","LENZ","BK4007"],"gpt_icon":0},{"id":"2571533463","title":"Black Diamond Therapeutics, Inc.盘中异动 早盘快速拉升5.29%报3.58美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2571533463","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2571533463?lang=zh_cn&edition=full","pubTime":"2025-09-29 21:52","pubTimestamp":1759153945,"startTime":"0","endTime":"0","summary":"北京时间2025年09月29日21时52分，Black Diamond Therapeutics, Inc.股票出现异动，股价急速拉升5.29%。Black Diamond Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.83%。其相关个股中，Dogwood Therapeutics, Inc.、Merus N.V.、Dermata Therapeutics Inc C/Wts 涨幅较大，Dogwood Therapeutics, Inc.、Kala Bio, Inc.、Plus Therapeutics, Inc.较为活跃，换手率分别为1805.70%、182.40%、59.63%，振幅较大的相关个股有Prelude Therapeutics Incorporated、Zura Bio Limited、Dogwood Therapeutics, Inc.，振幅分别为46.60%、34.85%、30.62%。Black Diamond Therapeutics, Inc.公司简介：Black Diamond Therapeutics Inc 是一家临床阶段的肿瘤学公司，开发针对癌症患者致癌突变家族的 MasterKey 疗法。其在研药物为 BDTX-4933 和 BDTX-1535。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250929215225a6a66f4f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250929215225a6a66f4f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","BDTX","LENZ","BK4007"],"gpt_icon":0},{"id":"2561828297","title":"Black Diamond Therapeutics, Inc.盘中异动 股价大涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2561828297","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561828297?lang=zh_cn&edition=full","pubTime":"2025-08-22 21:46","pubTimestamp":1755870385,"startTime":"0","endTime":"0","summary":"北京时间2025年08月22日21时46分，Black Diamond Therapeutics, Inc.股票出现异动，股价大幅上涨5.10%。Black Diamond Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。其相关个股中，Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Pmgc Holdings Inc.、Azitra Inc涨幅较大，Pmgc Holdings Inc.、Azitra Inc、Genprex, Inc.较为活跃，换手率分别为3464.69%、444.71%、203.86%，振幅较大的相关个股有Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Pmgc Holdings Inc.、Liminatus Pharma, Inc.，振幅分别为198.87%、47.09%、34.89%。Black Diamond Therapeutics, Inc.公司简介：Black Diamond Therapeutics Inc 是一家临床阶段的肿瘤学公司，开发针对癌症患者致癌突变家族的 MasterKey 疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250822214625975918c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250822214625975918c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4539","BDTX","BK4007"],"gpt_icon":0},{"id":"2559662649","title":"Black Diamond Therapeutics, Inc.盘中异动 早盘急速拉升5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2559662649","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559662649?lang=zh_cn&edition=full","pubTime":"2025-08-12 21:30","pubTimestamp":1755005432,"startTime":"0","endTime":"0","summary":"北京时间2025年08月12日21时30分，Black Diamond Therapeutics, Inc.股票出现异动，股价急速上涨5.19%。Black Diamond Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，180 Life Sciences Corp C/Wts 07/11/2025、180 Life Sciences Corp.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大，Tnf Pharmaceuticals, Inc.、X4制药、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为737.54%、443.11%、71.46%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Tuhura Biosciences, Inc.、Relmada Therapeutics, Inc.，振幅分别为13.57%、11.64%、10.83%。Black Diamond Therapeutics, Inc.公司简介：Black Diamond Therapeutics Inc 是一家临床阶段的肿瘤学公司，开发针对癌症患者致癌突变家族的 MasterKey 疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081221303297431b9d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081221303297431b9d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BDTX","BK4539","BK4007","BK4139","LENZ"],"gpt_icon":0},{"id":"2557930526","title":"Black Diamond Therapeutics, Inc.盘中异动 早盘股价大跌5.12%报2.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557930526","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557930526?lang=zh_cn&edition=full","pubTime":"2025-08-06 22:48","pubTimestamp":1754491697,"startTime":"0","endTime":"0","summary":"北京时间2025年08月06日22时48分，Black Diamond Therapeutics, Inc.股票出现异动，股价快速跳水5.12%。Black Diamond Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.23%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Biomx Inc.、Bioxcel Therapeutics, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Biomx Inc.、Psyence Biomedical Ltd.较为活跃，换手率分别为597.86%、350.31%、53.15%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Cingulate Inc C/Wts 10/12/2026 ，振幅分别为45.15%、44.74%、36.81%。Black Diamond Therapeutics, Inc.公司简介：Black Diamond Therapeutics Inc 是一家临床阶段的肿瘤学公司，开发针对癌症患者致癌突变家族的 MasterKey 疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080622481794d39a8a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080622481794d39a8a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4539","BDTX","BK4007"],"gpt_icon":0},{"id":"2556387066","title":"Black Diamond Therapeutics, Inc.盘中异动 早盘大幅上涨5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556387066","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556387066?lang=zh_cn&edition=full","pubTime":"2025-08-04 22:08","pubTimestamp":1754316525,"startTime":"0","endTime":"0","summary":"北京时间2025年08月04日22时08分，Black Diamond Therapeutics, Inc.股票出现波动，股价快速拉升5.41%。Black Diamond Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.74%。其相关个股中，Psyence Biomedical Ltd.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、凯信远达涨幅较大，Psyence Biomedical Ltd.、Soligenix, Inc.、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为4798.06%、1208.04%、479.72%，振幅较大的相关个股有凯信远达、Psyence Biomedical Ltd.、Soligenix, Inc.，振幅分别为69.68%、64.62%、35.95%。Black Diamond Therapeutics, Inc.公司简介：Black Diamond Therapeutics Inc 是一家临床阶段的肿瘤学公司，开发针对癌症患者致癌突变家族的 MasterKey 疗法。其在研药物为 BDTX-4933 和 BDTX-1535。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804220846a4749f3d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804220846a4749f3d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","BK4139","BK4539","BDTX"],"gpt_icon":0},{"id":"2556085827","title":"Black Diamond Therapeutics, Inc.盘中异动 急速跳水5.50%报2.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556085827","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556085827?lang=zh_cn&edition=full","pubTime":"2025-08-01 03:11","pubTimestamp":1753989097,"startTime":"0","endTime":"0","summary":"北京时间2025年08月01日03时11分，Black Diamond Therapeutics, Inc.股票出现异动，股价急速下挫5.50%。Black Diamond Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.60%。其相关个股中，Soligenix, Inc.、Silexion Therapeutics Corp、Celularity Inc C/Wts 16/07/2026 涨幅较大，Soligenix, Inc.、Psyence Biomedical Ltd.、Onconetix, Inc.较为活跃，换手率分别为11261.77%、5139.36%、4943.97%，振幅较大的相关个股有Soligenix, Inc.、Silexion Therapeutics Corp、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 ，振幅分别为297.60%、97.88%、97.44%。Black Diamond Therapeutics, Inc.公司简介：Black Diamond Therapeutics Inc 是一家临床阶段的肿瘤学公司，开发针对癌症患者致癌突变家族的 MasterKey 疗法。其在研药物为 BDTX-4933 和 BDTX-1535。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801031137972ae4ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801031137972ae4ff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4539","BDTX","BK4139"],"gpt_icon":0},{"id":"2555040086","title":"Black Diamond Therapeutics, Inc.盘中异动 急速拉升5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555040086","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555040086?lang=zh_cn&edition=full","pubTime":"2025-07-30 21:59","pubTimestamp":1753883946,"startTime":"0","endTime":"0","summary":"北京时间2025年07月30日21时59分，Black Diamond Therapeutics, Inc.股票出现波动，股价快速拉升5.01%。Black Diamond Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.37%。Black Diamond Therapeutics, Inc.公司简介：Black Diamond Therapeutics Inc 是一家临床阶段的肿瘤学公司，开发针对癌症患者致癌突变家族的 MasterKey 疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507302159069727ea7f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507302159069727ea7f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BDTX","LENZ","BK4539","BK4007","BK4139"],"gpt_icon":0},{"id":"2555205228","title":"Black Diamond Therapeutics, Inc.盘中异动 早盘大幅跳水5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555205228","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555205228?lang=zh_cn&edition=full","pubTime":"2025-07-29 21:55","pubTimestamp":1753797340,"startTime":"0","endTime":"0","summary":"北京时间2025年07月29日21时55分，Black Diamond Therapeutics, Inc.股票出现异动，股价快速跳水5.12%。Black Diamond Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.07%。其相关个股中，180 Life Sciences Corp C/Wts 07/11/2025、Surrozen Inc C/Wts 01/08/2031 、Calidi Biotherapeutics, Inc.涨幅较大，Scinai Immunotherapeutics Ltd、Tnf Pharmaceuticals, Inc.、Calidi Biotherapeutics, Inc.较为活跃，换手率分别为3514.19%、1334.01%、371.50%，振幅较大的相关个股有180 Life Sciences Corp C/Wts 07/11/2025、Adial Pharmaceuticals, Inc、Scinai Immunotherapeutics Ltd，振幅分别为106.73%、46.98%、43.41%。Black Diamond Therapeutics, Inc.公司简介：Black Diamond Therapeutics Inc 是一家临床阶段的肿瘤学公司，开发针对癌症患者致癌突变家族的 MasterKey 疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072921554197258f08&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072921554197258f08&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BDTX","LENZ","BK4139","BK4539","BK4007"],"gpt_icon":0},{"id":"2518208823","title":"Black Diamond Therapeutics, Inc.盘中异动 股价大跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518208823","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518208823?lang=zh_cn&edition=full","pubTime":"2025-03-11 00:20","pubTimestamp":1741623617,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日00时20分，Black Diamond Therapeutics, Inc.股票出现异动，股价快速下跌5.05%。Black Diamond Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.32%。其相关个股中，Mineralys Therapeutics, Inc.、Checkpoint Therapeutics, Inc.、Aeon Biopharma, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Aeon Biopharma, Inc.、Scisparc Ltd.较为活跃，换手率分别为3704.52%、3188.46%、944.65%，振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 29/04/2026 、Aeon Biopharma, Inc.、Scisparc Ltd.，振幅分别为88.14%、78.32%、49.87%。Black Diamond Therapeutics, Inc.公司简介：Black Diamond Therapeutics Inc 是一家精密肿瘤药物公司。该公司有一个研发管线技术平台，即针对癌症突变的Mutation-Allostery-Pharmacology。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311002018a26a62fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311002018a26a62fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BDTX","BK4139"],"gpt_icon":0},{"id":"2518728166","title":"Black Diamond Therapeutics, Inc.2024财年实现净利润-69.68百万美元，同比增加15.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518728166","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518728166?lang=zh_cn&edition=full","pubTime":"2025-03-10 00:01","pubTimestamp":1741536076,"startTime":"0","endTime":"0","summary":"3月10日，Black Diamond Therapeutics, Inc.公布财报，公告显示公司2024财年净利润为-69.68百万美元，同比增加15.48%；其中营业收入为0.00美元，每股基本收益为-1.27美元。从资产负债表来看，Black Diamond Therapeutics, Inc.总负债39.36百万美元，其中短期债务3.40百万美元，资产负债比为0.04，流动比率为0.05。机构评级：截至2025年3月10日，当前有5家机构对Black Diamond Therapeutics, Inc.目标价做出预测，其中目标均价为14.00美元，其中最低目标价为9.00美元，最高目标价为20.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000237a2689875&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000237a2689875&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BDTX","LENZ"],"gpt_icon":0},{"id":"2517535444","title":"Stifel：维持Black Diamond Therapeutic(BDTX.US)评级，由买入调整至买入评级, 目标价由16.00美元调整至15.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517535444","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517535444?lang=zh_cn&edition=full","pubTime":"2025-03-08 00:52","pubTimestamp":1741366373,"startTime":"0","endTime":"0","summary":"Stifel：维持Black Diamond Therapeutic(BDTX.US)评级，由买入调整至买入评级, 目标价由16.00美元调整至15.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/08005248604792.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BDTX"],"gpt_icon":0},{"id":"1154699655","title":"Black Diamond Therapeutics第四季度每股亏损$(0.28)，好于预期$(0.31)","url":"https://stock-news.laohu8.com/highlight/detail?id=1154699655","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1154699655?lang=zh_cn&edition=full","pubTime":"2025-03-07 05:07","pubTimestamp":1741295220,"startTime":"0","endTime":"0","summary":"Black Diamond Therapeutics报告第四季度每股亏损$，好于分析师预期的$，比预期高出9.68%。与去年同期的每股亏损$相比，这一数据增长了17.65%。以上内容来自Benzinga Earnings专栏，原文如下：Black Diamond Therapeutic  reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 9.68 percent. This is a 17.65 percent increase over losses of $ per share from the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BDTX","BDE"],"gpt_icon":0},{"id":"2516527406","title":"Black Diamond Therapeutics, Inc.盘中异动 股价大跌5.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516527406","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516527406?lang=zh_cn&edition=full","pubTime":"2025-03-04 02:53","pubTimestamp":1741027991,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日02时53分，Black Diamond Therapeutics, Inc.股票出现异动，股价大幅下挫5.46%。Black Diamond Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.59%。其相关个股中，Bioxcel Therapeutics, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Radiopharm Theranostics Limited涨幅较大，Bioxcel Therapeutics, Inc.、Allarity Therapeutics, Inc.、Entero Therapeutics Inc.较为活跃，换手率分别为4445.09%、200.45%、180.24%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Entero Therapeutics Inc.，振幅分别为206.20%、119.50%、70.53%。Black Diamond Therapeutics, Inc.公司简介：Black Diamond Therapeutics Inc 是一家精密肿瘤药物公司。该公司有一个研发管线技术平台，即针对癌症突变的Mutation-Allostery-Pharmacology。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304025311abe67d69&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304025311abe67d69&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BDTX","LENZ","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.blackdiamondtherapeutics.com","stockEarnings":[{"period":"1week","weight":0.0495},{"period":"1month","weight":-0.0934},{"period":"3month","weight":-0.3868},{"period":"6month","weight":-0.2021},{"period":"1year","weight":0.0219},{"period":"ytd","weight":-0.0412}],"compareEarnings":[{"period":"1week","weight":0.0113},{"period":"1month","weight":0.0059},{"period":"3month","weight":0.0461},{"period":"6month","weight":0.0684},{"period":"1year","weight":0.1295},{"period":"ytd","weight":0.011}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Black Diamond Therapeutics, Inc.于2014年12月在特拉华州成立。该公司是一家临床阶段的肿瘤学公司，专注于开发用于治疗基因定义肿瘤患者的MasterKey疗法。该公司的目标是基因定义癌症患者中不存在药物的致癌驱动基因突变。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.139571},{"month":2,"riseRate":0.285714,"avgChangeRate":-0.109158},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.083771},{"month":4,"riseRate":0.666667,"avgChangeRate":0.068656},{"month":5,"riseRate":0.5,"avgChangeRate":-0.050797},{"month":6,"riseRate":0.666667,"avgChangeRate":0.380267},{"month":7,"riseRate":0.5,"avgChangeRate":-0.00251},{"month":8,"riseRate":0.666667,"avgChangeRate":-0.009829},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.106486},{"month":10,"riseRate":0.5,"avgChangeRate":-0.063219},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.007717},{"month":12,"riseRate":0.166667,"avgChangeRate":-0.108792}],"exchange":"NASDAQ","name":"Black Diamond Therapeutics, Inc.","nameEN":"Black Diamond Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Black Diamond Therapeutics, Inc.(BDTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Black Diamond Therapeutics, Inc.(BDTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Black Diamond Therapeutics, Inc.,BDTX,Black Diamond Therapeutics, Inc.股票,Black Diamond Therapeutics, Inc.股票老虎,Black Diamond Therapeutics, Inc.股票老虎国际,Black Diamond Therapeutics, Inc.行情,Black Diamond Therapeutics, Inc.股票行情,Black Diamond Therapeutics, Inc.股价,Black Diamond Therapeutics, Inc.股市,Black Diamond Therapeutics, Inc.股票价格,Black Diamond Therapeutics, Inc.股票交易,Black Diamond Therapeutics, Inc.股票购买,Black Diamond Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Black Diamond Therapeutics, Inc.(BDTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Black Diamond Therapeutics, Inc.(BDTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}